CMS exposed as drug shortages spread nationwide

Botswana’s worsening medicine shortage has sparked a heated parliamentary showdown, with Lobatse Member of Parliament Kamal Jacobs demanding accountability from health officials over persistent drug stock-outs in public facilities. The country’s public healthcare system is facing renewed scrutiny amid growing complaints from patients and healthcare workers about shortages of essential medicines, including drugs for chronic illnesses and emergency care. During the PAC hearing, Lobatse MP Kamal Jacobs expressed anger over recurring shortages and questioned whether CMS leadership had the capacity to resolve long-standing procurement and distribution challenges.

Jacobs told the committee that communities were suffering because patients were unable to access critical medication at government health facilities. He also raised concerns about possible internal failures within the medicine supply chain, suggesting that inefficiencies could be benefiting private pharmaceutical suppliers at the expense of public healthcare users. The MP’s remarks intensified debate over whether Botswana’s medicine crisis is a temporary supply challenge or evidence of deeper structural weaknesses within government procurement systems.

The PAC hearing highlighted several concerns affecting CMS operations, including delays in medicine procurement, weak stock management systems, distribution challenges, and financial losses caused by expired medicines. Health sector analysts have previously warned that medicine shortages are rarely caused by a single factor but usually emerge from a combination of poor forecasting, procurement delays, global supply disruptions, funding constraints, and weak inventory controls. According to the World Health Organization (WHO), effective medicine supply systems depend on accurate forecasting, transparent procurement processes, reliable storage facilities, and efficient distribution networks.

[paywall]

Countries that experience repeated stock-outs often face challenges in coordinating demand planning and maintaining adequate buffer stocks. Botswana, like many countries dependent on imported pharmaceuticals, has also been affected by global supply chain disruptions, currency pressures, and increased demand for healthcare services. Responding to the criticism, Acting Permanent Secretary in the Ministry of Health Dr.

Tshepo Machacha defended Dr. Paramadhas, saying his appointment followed established government procedures and was based on professional qualifications and experience. Machacha rejected suggestions that the CMS director was solely responsible for the medicine shortages, arguing that the challenges facing the system require broader interventions across procurement, logistics, and supplier management.

The ministry acknowledged that supply constraints exist but said it continues to work with international suppliers and other partners to restore stable medicine availability. The confrontation between MP Jacobs and health officials reflects growing public frustration over a healthcare system where medicine availability directly affects citizens’ trust in government services. While political accountability is necessary, experts argue that resolving Botswana’s medicine shortages requires more than changing individuals in leadership positions.

The crisis points to the need for stronger supply-chain governance, improved digital tracking of medicines, better demand forecasting, and independent monitoring mechanisms to detect failures before they affect patients. The government’s challenge is balancing immediate solutions, such as emergency medicine procurement, with long-term reforms that strengthen CMS efficiency. Without structural improvements, Botswana risks repeatedly returning to crisis management whenever supply disruptions occur. The PAC interrogation has therefore reopened a broader debate: whether Botswana’s healthcare challenges are caused by temporary operational failures or whether they expose deeper weaknesses in public sector planning, procurement accountability, and institutional capacity.

[/paywall]